A lawsuit has been filed in the US by a patient with Type 2 diabetes who was prescribed Byetta and Janumet and later developed pancreatic cancer. The suit was announced by Rheingold, Valet, Rheingold, McCartney & Giuffra LLP in New York. ---Subscribe to MedNous to access this article--- Company News IPR & Legal
